Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS should be screened for heart disease risk and manage their health to prevent it.

Premature hair graying may be a sign of increased risk for heart disease, indicating biological age is more important than actual age.

Women with PCOS have higher renin and d-dimer levels, especially if they have COVID-19.

Rosuvastatin improves lipid levels, reduces inflammation, but worsens insulin sensitivity in men with early-onset hair loss.

Women with non-classic congenital adrenal hyperplasia have higher risk for heart and metabolic problems.

Metreleptin treatment significantly improved metabolic health in a boy with congenital generalized lipodystrophy.

Women with PCOS have altered brain structure and reduced cognitive performance.

Androgen replacement therapy can improve libido and mood in women with severe androgen deficiency, but more research is needed on its long-term safety.

The removed ovarian tumor was a rare type of blood vessel tumor that improved the patient's symptoms and hormone levels after surgery.

Improving artificial vascular grafts requires better materials and surface designs to reduce blood clotting and support blood vessel cell growth.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Finasteride safely lowers DHT levels without affecting testosterone.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Hirsutism is a strong sign of high male hormones and metabolic problems in women with PCOS, but acne and hair loss are not.

Baldness caused by male hormones in female-to-male transsexuals doesn't increase the risk of heart disease.

Certain microRNAs in the fluid around eggs are linked to Polycystic Ovary Syndrome and may help diagnose it.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Obese women with PCOS are more likely to have fatty liver disease.

Cyproterone acetate is effective for treating hirsutism and acne but less so for hair loss, with side effects similar to birth control pills.

Vitamin D deficiency is common in women with PCOS and linked to some metabolic problems, but not the main cause of their metabolic issues.

Microemulsions could improve how drugs are delivered and absorbed in the body.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

A 33-year-old woman with PCOS and metabolic syndrome was unusually diagnosed with a bone condition called DISH, suggesting a possible link between these conditions.

People with Alopecia Areata have a higher risk of heart-related health issues.

People with a family history of hair loss are more likely to experience it, and the severity of hair loss is linked to insulin resistance. The connection between early hair loss and oxidative stress needs more investigation.

Adolescent females with PCOS have higher serum cystatin C levels, indicating potential metabolic and cardiovascular issues.

Kolaviron and quercetin may help treat prostate issues.

Hormonal imbalances, not insulin resistance or dyslipidemia, may be more important in causing acne in women over 25.

Skin tags may be linked to metabolic syndrome.

Obesity is an independent risk factor for early coronary artery disease (CAD) and its severity is not affected by age.